Rafael Leon-Lopez
Overview
Explore the profile of Rafael Leon-Lopez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
73
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Matuozzo D, Talouarn E, Marchal A, Zhang P, Manry J, Seeleuthner Y, et al.
Genome Med
. 2024 Jan;
16(1):6.
PMID: 38184654
No abstract available.
2.
Trigo-Rodriguez M, Carcel S, Navas A, Espindola-Gomez R, Garrido-Gracia J, Esteban Moreno M, et al.
Open Forum Infect Dis
. 2023 Apr;
10(4):ofad133.
PMID: 37035487
Background: The Clinical Trial of Sarilumab in Adults With COVID-19 (SARICOR) showed that patients with coronavirus disease 2019 (COVID-19) pneumonia and increased levels of interleukin (IL)-6 might benefit from blockade...
3.
Matuozzo D, Talouarn E, Marchal A, Zhang P, Manry J, Seeleuthner Y, et al.
Genome Med
. 2023 Apr;
15(1):22.
PMID: 37020259
Background: We previously reported that impaired type I IFN activity, due to inborn errors of TLR3- and TLR7-dependent type I interferon (IFN) immunity or to autoantibodies against type I IFN,...
4.
Matuozzo D, Talouarn E, Marchal A, Manry J, Seeleuthner Y, Zhang Y, et al.
medRxiv
. 2022 Nov;
PMID: 36324795
Background: We previously reported inborn errors of TLR3- and TLR7-dependent type I interferon (IFN) immunity in 1-5% of unvaccinated patients with life-threatening COVID-19, and auto-antibodies against type I IFN in...
5.
Bergin S, Calvert S, Farley J, Sun J, Chiswell K, Dieperink W, et al.
Open Forum Infect Dis
. 2022 Jul;
9(7):ofac231.
PMID: 35836748
Background: The prospective identification of patients at high risk for hospital-acquired/ventilator-associated bacterial pneumonia may improve clinical trial feasibility and foster antibacterial development. In a prior study conducted in the United...
6.
Fernandez-Martinez N, Carcel-Fernandez S, De la Fuente-Martos C, Ruiz-Montero R, Guzman-Herrador B, Leon-Lopez R, et al.
Int J Environ Res Public Health
. 2022 Feb;
19(3).
PMID: 35162062
Multidrug-resistant Gram-negative bacteria (MDR-GNB) are microorganisms that have acquired resistance to extended-spectrum antibacterials and constitute an emerging threat to public health. Although carriers are an important source of transmission in...
7.
Merchante N, Carcel S, Garrido-Gracia J, Trigo-Rodriguez M, Esteban Moreno M, Leon-Lopez R, et al.
Antimicrob Agents Chemother
. 2021 Dec;
66(2):e0210721.
PMID: 34902262
The objective of this study was to investigate the efficacy and safety of early treatment with sarilumab, added to standard of care (SOC), in hospitalized adults with COVID-19. Methods included...
8.
Morales-Cane I, Lopez-Soto P, Valverde-Leon M, Moral-Arroyo J, Leon-Lopez R, Rodriguez-Borrego M
Int J Nurs Pract
. 2020 May;
26(5):e12853.
PMID: 32453480
Aims: Our study examined factors influencing the development of healthcare-associated infections in the intensive care unit (ICU) of a tertiary hospital in southern Spain. Background: Healthcare-associated infections are a frequent...
9.
Llompart-Pou J, Chico-Fernandez M, Sanchez-Casado M, Alberdi-Odriozola F, Guerrero-Lopez F, Mayor-Garcia M, et al.
Injury
. 2016 Oct;
47 Suppl 3:S61-S65.
PMID: 27692109
Background: Injury patterns may differ in trauma patients when age is considered. This information is relevant in the management of trauma patients and for planning preventive measures. Methods: We included...